Frankfurt - Delayed Quote EUR
Galapagos NV (GXE.F)
25.16
-0.26
(-1.02%)
At close: May 30 at 9:48:34 PM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-236,199
-320,026
-405,970
-500,544
-503,827
Investing Cash Flow
275,677
220,597
71,186
-1,245,514
541,238
Financing Cash Flow
-4,767
-4,924
-5,001
-1,487
-3,876
End Cash Position
108,083
64,239
166,810
508,117
2,233,368
Capital Expenditure
-81,098
-82,110
-19,273
-36,947
-57,879
Issuance of Capital Stock
--
--
--
--
0
Repayment of Debt
-4,767
-4,924
-6,771
-8,182
-7,190
Free Cash Flow
-317,297
-402,136
-425,243
-537,491
-561,706
12/31/2021 - 6/28/2005
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
9WV.BE Nutriband Inc
5.60
+2.75%
25I.SG ImmuPharma PLC
0.0210
-20.75%
600161.SS TIANTAN BIO
19.13
-0.52%
8EM.BE Editas Medicine Inc
1.5635
-4.75%
RXK3.MU SELLAS Life Sciences Group Inc
1.4940
-2.67%
BCX.WA Bioceltix S.A.
103.80
-4.07%
0M4.F Mersana Therapeutics, Inc.
0.2546
-1.36%
ATOS.MX Atossa Therapeutics, Inc.
16.00
0.00%
22Z.SG Zealand Pharma A/S
60.78
+0.10%
GYX.F Futura Medical plc
0.0870
+2.35%